BOSTON, May 29, 2025 /PRNewswire/ -- Myasthenia Gravis Foundation of America (MGFA ™), the largest, leading patient advocacy organization in the United States solely dedicated to the myasthenia gravis ...
Argenx is launching its first awareness efforts for autoimmune disease myasthenia gravis. The campaign began recently with a virtual conference, light-up nights around the country, a patient website ...
Johnson & Johnson doesn’t even have a potential FDA approval on the horizon for its myasthenia gravis (MG) hopeful nipocalimab. But the Big Pharma, aware of its rivals pulling away, is already zeroing ...
More than 1,600 people have signed a petition calling for greater awareness about Myasthenia Gravis (MG), a rare and often debilitating disease, and would like to see collective action that will ...
June is MG Awareness Month – Global campaigns focus on patient and caregiver inspiration, support and education, and community action to promote broader understanding of rare disease BOSTON, May 29, ...
June is MG Awareness Month – Global campaigns focus on patient and caregiver inspiration, support and education, and community action to promote broader understanding of rare disease Approximately ...
Global myasthenia gravis community taking action in June to spread awareness about rare disease and highlight debilitating challenges experienced by patients. BOSTON, June 1, 2023 /PRNewswire/ -- The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results